• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Prinston`s Generic Candesartan Cilexetil Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of September 22, 2021

    FDA

    Enforcement Report - Week of April 21, 2021

    FDA

    AstraZeneca divests Atacand commercial rights to Cheplapharm

    PHARMACEUTICAL-TECHNOLOGY

    Atacand divestment to Cheplapharm in more than 70 countries completed

    PRESS RELEASE

    Enforcement Report - Week of January 23, 2019

    FDA

    43 popular heart drugs found to contain carcinogens in Taiwan

    TAIWAN NEWS

    FDA presents interim limits of nitrosamines in currently marketed ARBs

    FDA

    Alembic Pharms` Generic Candesartan Cilexetil Receives Approval in US

    FDA

    Valsartan from Mylan laboratories in India can no longer be used in EU medicines due to NDEA impurity

    EMA

    Questions and Answers: Impurities found in certain generic angiotensin II receptor blocker (ARB) products

    FDA

    EU authorities take further action in ongoing review of sartans

    EMA

    Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with GMP

    HEALTH CANADA

    EMA review of impurities in sartan medicines

    PRESS RELEASE

    Prinston’s Generic Candesartan Cilexetil:Hydrochlorothiazide Receives Approval In US

    FDA

    ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million

    PR NEWSWIRE

    Zydus Pharm’s Generic Candesartan Cilexetil; Hydrochlorothiazide Receives Approval In US

    FDA

    Zydus Pharm’s Generic Candesartan Cilexetil Receives Approval In US

    FDA

    Macleods`s Generic Candesartan Cilexetil Receives Approval In US

    FDA

    Anvisa suspends lots of medication for high blood pressure

    ANVISA

    Amerisource Health Services recalls Candesartan Cilexetil Tablets, 16 mg, 30 Tablets due to Failed Impurities/Degradation Specifications

    FDA

    Sandoz Inc recalls lots of Candesartan Cilexetil Tablets due to Failed Impurities/Degradation Specifications

    FDA

    APO-Candesartan / HCTZ Product Recall (2015-05-19)

    HEALTHY CANADIANS

    Apotex initiated recall of one additional lot of APO-Candesartan

    HEALTH CANADA

    Apotex Product Recalled by Health Canada

    HEALTHY CANADIANS

    Nova Southeastern University Researcher Discovers Certain ARB Drugs Are More Effective Than Others at Treating Heart Failure

    BIOSPACE

    NSU Researcher Discovers Certain ARB Drugs Are More Effective Than Others at Treating Heart Failure

    NOVA SOUTHEASTERN UNIVERSITY

    EMA Recommends Hundreds of Drugs to be Suspended Over "Flawed Studies"

    PHARMALOT

    Takeda and Teva set out generics joint venture plan

    PHARMAFILE

    German Drugmakers Appeal Drug Suspensions Linked to Indian Data

    REUTERS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.